VCaP androgen-independent cell line
Invented at Northern Institute For Cancer Research, Newcastle University
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 154161 |
| Parental Line | VCaP |
| Host | Human |
| Disease Keywords | Human prostate adenocarcinoma |
| Model | Tumour line |
| Relevance |
VCaP cells are androgen-sensitive human prostate adenocarcinoma cells established in 1997 from a vertebral bone metastasis from a 59-year-old Caucasian male with hormone refractory prostate cancer. This cell line is commonly used for prostate cancer research. The cell line is a clonal population of VCaP cells grown in steroid-depleted conditions for ~4 months. Cells adapted to growth conditions and are now routinely grown in media lacking testosterone |
| Production Details | VCaP cells grown in steroid-depleted conditions for ~4 months |
| Conditional | No |
| Research Area | Cancer |
| Recommended Growing Conditions | DMEM + 10% FBS |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
